A- A A+

About Us Mandate Objectives Collaboration Details Education & Courses Contact Us

About Us

NCG Clinical Trial Network

In November 2020, a clinical trial network in oncology was established under the National Cancer Grid with the grant from Biotechnology Industry Research Assistance Council, (BIRAC).

The purpose of this clinical trial network is to strengthen the clinical trial capacity across member centres to promote multi-centric high-quality trials. The network will  provide a uniform platform to support innovation and development of biosimilars. The network has 11 centres with Tata Memorial Centre being the coordinating centre.



To establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative research in the field of drug and device development



 A. Capacity building across all the sites of Network

 B. Patient registry between the site network.

 C. To make the site ready for clinical trial conduct.



NCG and BIRAC CTN Network

S. No.

 Name of Institute


PI details


Tata Memorial Hospital

Mumbai, MH



Advanced Center for Treatment Research and Education in Cancer (ACTREC)

Navi Mumbai, MH

Dr. Jayant SastriGoda


Dr. Bhubaneswar Borooah Cancer Institute

Guwahati, Assam

Dr Ashok Kumar Das


Homi Bhabha Cancer Hospital

Varanasi, UP

Dr.Satyajit Pradhan


Cancer Institute WIA

Chennai, Tamil Nadu

Dr. G.Selvaluxmy


Malabar Cancer Centre 

Thalassery, Kerala

Dr.Satheesan B


Max Super Specialty Hospital

Saket, New Delhi

Dr. Ramandeep Arora


North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS)

Shillong, Meghalaya

Dr. Caleb Harris


Regional Cancer Centre

Thiruvananthapuram, Kerala

Dr.Beela Sarah Mathew


Christian Medical College

Vellore, Tamil Nadu

Dr. Vikram Mathews


Cachar Cancer Hospital and Research Center (CCHRC)

Silchar, Assam

Dr. Ravi Kannan

Salient Points:

    1. Uniform common network SOPs for clinical trial conduct.

    2. Trained manpower: The network has trained its manpower consisting of Project Manager (PM), Clinical Research Coordinator (CRC), Research Nurse, Research Pharmacist, Research Biostatistician, etc. in Good Clinical Practice (GCP), New Drug Clinical Trial rules 2019 (NDCT-2019), Indian Council of Medical Research (ICMR) guidelines, stakeholder responsibilities, monitoring, auditing, inspections and related clinical research topics.

    3. All the centres in the network have either a well-established clinical research pharmacy or a dedicated space for clinical research drugs in the existing respective institutional pharmacy.

    4. All the centres have a secured and well-equipped data storage facilities.

    5. The network member centres have developed and established a common cancer registry for disease areas: Breast, Colorectal, Lung, Gall Bladder, Lymphoma and Chronic MyloidLeukemia (CML). The registry captures following information: Demographics, History, Examination, Histopathology, Treatment Plan, Toxicity and Follow-up.


Education & Training


           - Clinical trial awareness materials for patients: 

            - Patient Awareness - English 

            - Patient Awareness - Marathi 

            - Patient Awareness - Hindi  



Contact Us

In case a particular sponsor is interested to conduct a clinical trial, the sponsor may drop an email to This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone: Hospital Number: +91-22-24177000, Extn: 4274

Address: Tata Memorial Hospital, CRS, 3 Floor, Main Building, Dr. E Borges Road, Parel, Mumbai - 400 012 India

Email-id: Email-id: This email address is being protected from spambots. You need JavaScript enabled to view it. (For Patient Queries)

Color Switch

Go to top